School personnel information

写真b

HOSEN Naoki


Keyword

hematology, oncology, stem cell biology, cancer immunology

Mail Address

Mail Address

Gender

Male

Organization 【 display / non-display

  • 2007.04.01 - 2007.04.30, Division of Health Sciences, Graduate School of Medicine, Specially Appointed Researcher

  • 2007.05.01 - 2009.03.31, Graduate School of Medicine, Associate Professor

  • 2009.04.01 - 2014.03.31, Division of Health Sciences, Graduate School of Medicine, Associate Professor

  • 2014.04.01 - 2019.12.31, Division of Health Sciences, Graduate School of Medicine, Associate Professor

  • 2020.01.01 - , Division of Medicine, Graduate School of Medicine, Professor

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated 1994.03
Osaka University Graduate School, Division of Medical Sciences  Completed Ph.D 2002.03

Research topics 【 display / non-display

  • Development of novel cancer immunotherapies
    Hematology and medical oncology-related, Tumor diagnostics and therapeutics-related

  • Hematology and medical oncology-related, Experimental pathology-related

 

Academic Papers 【 display / non-display

  • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma., Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H, Cancer immunology, immunotherapy : CII,68(2) 331-340, 2019.02, Other

  • Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells., Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, Nakanishi Y, Suga Y, Nishijima-Futami Y, Osa A, Nakatani T, Kato Y, Nishide M, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Kang S, Minami T, Hirata H, Iwahori K, Takimoto T, Takamatsu H, Takeda Y, Hosen N, Hoshino S, Shintani Y, Okumura M, Kumagai T, Nishino K, Imamura F, Nakatsuka SI, Kijima T, Kida H, Kumanogoh A, JCI insight,3(24), 2018.12, Other

  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides., Nakata J, Nakajima H, Hayashibara H, Imafuku K, Morimoto S, Fujiki F, Motooka D, Okuzaki D, Hasegawa K, Hosen N, Tsuboi A, Oka Y, Kumanogoh A, Oji Y, Sugiyama H, Oncotarget,9(89) 36029-36038, 2018.11, Papers

  • Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity., Morimoto S, Fujiki F, Kondo K, Nakajima H, Kobayashi Y, Inatome M, Aoyama N, Nishida Y, Tsuboi A, Oka Y, Nishida S, Nakata J, Hosen N, Oji Y, Sugiyama H., Oncotarget.,9(75) 34132-34141, 2018.09, Papers

  • WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies., Oji Y, Inoue M, Takeda Y, Hosen N, Shintani Y, Kawakami M, Harada T, Murakami Y, Iwai M, Fukuda M, Nishida S, Nakata J, Nakae Y, Takashima S, Shirakata T, Nakajima H, Hasegawa K, Kida H, Kijima T, Morimoto S, Fujiki F, Tsuboi A, Morii E, Morita S, Sakamoto J, Kumanogoh A, Oka Y, Okumura M, Sugiyama H, International journal of cancer,142(11) 2375-2382, 2018.06, Other

display all >>